Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Allred

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Pathology|January 1, 1993
Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer?D C Allred
Journal of Mammary Gland Biology and Neoplasia|February 21, 2004
Introduction: models of premalignant breast diseaseD C Allred, D Medina
Cancer|February 1, 1993
Recessive oncogenesR Bookstein, D C Allred
Breast Cancer Research and Treatment|March 5, 1999
Prognostic and predictive value of p53 and p21 in breast cancerR M Elledge, D C Allred
Cancer|September 24, 1999
Caution concerning micrometastatic breast carcinoma in sentinel lymph nodesD C Allred, R M Elledge
Human Pathology|June 1, 1992
Improved methods of estimating mitotic activity in solid tumorsS G Hilsenbeck, D C Allred
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Biological features of premalignant disease in the human breastD C Allred, S K Mohsin
Journal of the National Cancer Institute|September 10, 1998
Biomarkers in benign breast disease: risk factors for breast cancerD C Allred, S G Hilsenbeck
American Journal of Clinical Pathology|February 9, 2000
Testing for erbB-2 by immunohistochemistry in breast cancerD C Allred, P E Swanson
Breast Cancer Research and Treatment|January 1, 1994
The p53 tumor suppressor gene in breast cancerR M Elledge, D C Allred
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Pathology|January 1, 1993
Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer?D C Allred
Journal of Mammary Gland Biology and Neoplasia|February 21, 2004
Introduction: models of premalignant breast diseaseD C Allred, D Medina
Cancer|February 1, 1993
Recessive oncogenesR Bookstein, D C Allred
Breast Cancer Research and Treatment|March 5, 1999
Prognostic and predictive value of p53 and p21 in breast cancerR M Elledge, D C Allred
Cancer|September 24, 1999
Caution concerning micrometastatic breast carcinoma in sentinel lymph nodesD C Allred, R M Elledge
Human Pathology|June 1, 1992
Improved methods of estimating mitotic activity in solid tumorsS G Hilsenbeck, D C Allred
Journal of Mammary Gland Biology and Neoplasia|February 20, 2004
Biological features of premalignant disease in the human breastD C Allred, S K Mohsin
Journal of the National Cancer Institute|September 10, 1998
Biomarkers in benign breast disease: risk factors for breast cancerD C Allred, S G Hilsenbeck
American Journal of Clinical Pathology|February 9, 2000
Testing for erbB-2 by immunohistochemistry in breast cancerD C Allred, P E Swanson
Breast Cancer Research and Treatment|January 1, 1994
The p53 tumor suppressor gene in breast cancerR M Elledge, D C Allred
Pageof 8